Latest "Standard & Poor’s" News Stories - Page: 2

18:24 EDT 17th March 2018 | BioPortfolio

Here are the most relevant search results for "Standard & Poor’s" found in our extensive news archives from over 250 global news sources.

More Information about Standard & Poor’s on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Standard & Poor’s for you to read. Along with our medical data and news we also list Standard & Poor’s Clinical Trials, which are updated daily. BioPortfolio also has a large database of Standard & Poor’s Companies for you to search.

Showing "Standard Poor" News Articles 26–50 of 3,100+

Thursday 15th March 2018

Blue Shield of California Expands Palliative Care Program, Offers Home-Based Care Statewide

Innovative program also available to Medi-Cal beneficiaries enrolled with Care1st Health Plan, an affiliate of Blue Shield of California Blue Shield of California today announced it has expanded its home-based palliative care program statewide, becoming the only health plan in California to offer this service in all 58 counties. The expansion ...

Blood test company’s CEO accused of fraud, forced to pay $500K settlement

Body:  Elizabeth Holmes, a Stanford University dropout once likened to Steve Jobs, was forced to pay a $500,000 fine and give up her blood-testing company Theranos after securities regulators said she fraudulently raised more than $700 million from investors.Holmes gained national attention in 2013 when she claimed Theranos had developed a medical technology that could run thousands of medica...

Health Dialog Chief Medical Officer Dr. Peter Goldbach to Speak at National Quality Forum Workshop on Shared Decision Making

Workshop builds on March 12 release of National Quality Forum’s shared decision making playbook Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, announced today that Dr. Peter Goldbach, its chief medical officer, will join national adv...

Rural-urban differences in mid-Victorian British diets offer (possible) lessons for healthy eating today

Susan Perry In mid-Victorian Britain, poor people living in rural areas had better diets and health than their counterparts in urban areas, according to a study published recently in the Journal of the Royal Society of Medicine (JRSM) Open.As a result of their healthier eating habits, the rural residents of mid-19th-century Britain also tend...

Evotec AG (EVT-DE): A risk-diversified approach

goetzpartners securities Limited 15-March-2018 / 13:00 GMT/BST Free to access research and investor meetings in a post-MiFID2 world Evotec AG (EVT-DE): A risk-diversified approach Recommendation: OUTPERFORM Target Price: EUR19.40 (increased from EUR13.00) Current Price: EUR15.50 (cob on 14th March 2018) KEY TAKEAWAY The CRO market continues to be highly attractive and only a few playe...

Tokai-Denshi Developed A.I.-Equipped Portable Odor Detector/Identifier "Aino-Pro"

Tokai-Denshi Inc. and The Shizuoka Cancer Center Research Institute jointly developed an A.I.-based Portable Odor detector/Identifier which analyzes malodorous components emitted from cancer patients. This press release features multimedia. View the full release here:

20152023 World Brazing Rods Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 23022018] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

PsychoGenics Obtains License to the TgF344-AD Rat Model of Alzheimer’s Disease

Model exhibits oligomeric aβ, amyloid plaques, tau pathology, behavioral impairment, and neuronal loss PsychoGenics Inc. (PGI) announced today that it obtained a license from the National Institute of Mental Health (NIMH), part of the National Institutes of Health, to the TgF344-AD rat model of Alzheimer’s disease (AD). This model expresses mutant h...

Poor Adherence to Hepatocellular Carcinoma Surveillance

In this study, the current adherence rates to HCC surveillance guidelines are examined. Liver International

Macrolide Pharmaceuticals Presents New Data on Tool to Differentiate Macrolide Antibacterial Drugs by Risk of Liver Toxicity

The company’s approach aids in distinguishing liver-toxic ketolide antibiotics from safer macrolides that are widely used in the community and hospital settings. Macrolide Pharmaceuticals, a next-generation antibiotics company developing macrolides that are first-in-class with Gram-negative activity for a broad range of infections, today announced th...

Avedro Announces Agreement with the FDA for the First U.S. Pivotal Phase 3 Trial of an Epi-on Cross-Linking Treatment for Patients with Progressive Keratoconus

Procedure Includes New Drug Formulation and Use of Oxygen Avedro, Inc., an ophthalmic pharmaceutical and medical device company and the world leader in corneal remodeling, today announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol Assessment (SPA)

Novocure Announces 35 Presentations on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2018

The clinical and preclinical research to be presented includes the application of Tumor Treating Fields in seven cancer types Novocure (NASDAQ: NVCR) announced today 35 presentations on Tumor Treating Fields at the American Association for Cancer Research (AACR) Annual Meeting 2018, April 14 through April 18, in Chicago. Tumor Treating Fields is a canc...

Gamida Cell Appoints Shai Lankry as Chief Financial Officer

Gamida Cell, a leading cellular and immune therapeutics company, today announced the appointment of Shai Lankry, CPA, MBA, as chief financial officer (CFO). Mr. Lankry brings more than a decade of senior management experience in finance at both public and private companies to his new role as CFO of Gamida Cell. He succeeds Naftali Brikashvili, who will ...

Metrohm USA Collaborates with ASTM to Release New Test Method Measuring Harmful Organic Chlorides in Crude Oil

Metrohm USA is proud to announce the release of a new standard leveraging its Combustion Ion Chromatography (CIC) systems. This new standard, ASTM D8150, provides a test method for the determination of harmful organic chlorides in crude oil. Organic chlorides do not occur naturally in crude oil; they result from operations

Mercedes-Maybach GLS set for April reveal in Beijing: report

Mercedes-Benz is finally about to extend its Maybach super-luxury sub-brand beyond the S-Class. According to media reports, this new addition to the Maybach family will be an incredibly upmarket version of the upcoming third-generation GLS, which was previously the GL. With Land Rover continuing to set the standard in the luxury SUV market, and now Bentley making a huge impression with its Bent...


KEY FINDINGSNorth America accounted for a significant share of the global fetal and neonatal care equipment market in 2017 and is now further anticipated to dominate the market during the forecast period as well. By the end of 2027, the market is expected to register a CAGR of 4.80%, generating a total revenue of $4483 million.MARKET INSIGHTSCanada and U.S are the major markets in the North Americ...

Novavax: Flu vaccine failings due to 'outdated' egg-based manufacturing

Egg adaptation is the biggest culprit in this yearâs poor flu vaccine efficacy says Novavax, a firm developing a product based on recombinant protein nanoparticles.


ACACIA PHARMA'S BAREMSIS® PREVENTS POST-OPERATIVE NAUSEA & VOMITING IN HIGH-RISK PATIENTS Positive Phase 3 Clinical Trial Published in Peer-reviewed Journal, Anesthesiology Cambridge, UK and Indianapolis, US - 15 March 2018: Acacia Pharma Group plc ("Acacia Pharma", the "Company" or the "Group"), (EURONEXT: ACPH), a hospital pharmaceutical c...

4SC AG: Conference call to be hosted on 21 March 2018 to present the financial report 2017

DGAP-News: 4SC AG / Key word(s): Final Results 15.03.2018 / 07:30 The issuer is solely responsible for the content of this announcement. 4SC AG: Conference call to be hosted on 21 March 2018 to present the financial report 2017   Planegg-Martinsried, Germany, 15 March 2018 - 4SC AG (4SC, FSE Prime Standard: VSC) will publish its financial report 2017 on 21 March 2018. On this day...

SYGNIS AG: SYGNIS announces completion of Sales and Marketing team restructuring to support continued strong revenue growth (news with additional features)

DGAP-News: SYGNIS AG / Key word(s): Miscellaneous 15.03.2018 / 07:30 The issuer is solely responsible for the content of this announcement. PRESS RELEASE 15 March 2018   SYGNIS announces completion of Sales and Marketing team restructuring to support continued strong revenue growth   - Growth in team to over 30 staff over the past year - Reorganisation of team to focus on ...

Biotest AG: First patient with acquired fibrinogen deficiency treated in clinical phase III study of Biotest AG

DGAP-News: Biotest AG / Key word(s): Research Update 15.03.2018 / 07:00 The issuer is solely responsible for the content of this announcement. PRESS RELEASE First patient with acquired fibrinogen deficiency treated in clinical phase III study of Biotest AG - Important milestone reached in the clinical development programme of fibrinogen concentrate - Phase III study in acquired fibr...

Wednesday 14th March 2018

Higher doses of radiation don't improve survival in prostate cancer

(Washington University School of Medicine) A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology groups across North America, was led by researchers at Washington University School of Medicine in St. Louis.

Are too many people with arthritis having to wait for surgery?

Every year tens of thousands of people with osteoarthritis find joint replacement surgery offers them a new lease of life, enabling them to be more independent. But as the growing pressures on NHS resources hit the headlines again this winter, and stories o

Lung cancer subtype responsive to immunotherapy

Melbourne researchers have discovered that an aggressive lung cancer subtype is susceptible to immunotherapy, thanks to the identification of special markers expressed in tumours. The research was led by Dr Sarah Best and Dr Kate Sutherland from the Walter and Eliza Hall Institute (WEHI), working with colleagues at Metabolomics Australia at the University of Melbourne’s Bio21 Institute. Their s...

Beaird Dermatology Kicks Off “We Want to See You Naked” Campaign, Focused on Skin Cancer Screening and Treatment

Chicago Area Billboard Brings Attention-Getting Directive to Encourage Consumer Skin Checks at Beaird Dermatology, led by Dr. Leslie Beaird, has initiated a Chicago area campaign, “We Want to See You Naked”, designed to raise community awareness for “head to toe” skin exams, an important screening that identifies prec...

Quick Search


News Quicklinks